Shanghai Biologic

Shanghai Biological Products Institute (SIBP) is a leading Chinese biopharmaceutical company specializing in the research, development, and manufacturing of vaccines and blood-derived products. As a subsidiary of China National Biotec Group (CNBG) under Sinopharm, it plays a critical role in China's national immunization program and public health infrastructure. The company's portfolio includes a wide range of viral and bacterial vaccines, such as those for influenza, hepatitis B, and MMR, as well as therapeutic biologicals. SIBP operates large-scale GMP-certified manufacturing facilities and is a key player in the global supply of essential biologics. Its integrated capabilities span from early-stage R&D to commercial-scale production and distribution.